
Barbit60 mg
Incepta Pharmaceuticals Ltd.
Phenobarbital is a long-acting barbiturate with established anticonvulsant and sedative-hypnotic properties.
Phenobarbital is a long-acting barbiturate with established anticonvulsant and sedative-hypnotic properties. Its uses are classified below by strength of evidence.
| Indication | Typical Adult Dose |
|---|---|
| Seizure disorders (oral) | 50-100 mg two to three times daily, or 1-3 mg/kg/day as a single or divided dose; individualized to clinical response and, where available, serum levels (therapeutic range approximately 15-40 mcg/mL) |
| Sedation | 30-120 mg daily in divided doses |
| Short-term insomnia | 100-320 mg at bedtime, for short-term use only |
| Status epilepticus (IV, hospital setting) | Loading dose typically 15-20 mg/kg IV, administered slowly under continuous monitoring, followed by maintenance dosing |
| Indication | Typical Pediatric Dose |
|---|---|
| Seizure disorders (oral maintenance) | 3-6 mg/kg/day (higher relative doses may be needed in infants and young children due to faster clearance) |
| Neonatal seizures | Loading dose approximately 15-20 mg/kg IV under specialist/hospital supervision, followed by maintenance of 3-4 mg/kg/day |
Side effects of Phenobarbital are generally dose-related.
Phenobarbital is contraindicated in:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.